G09.F Genomic Vision Société Anonyme

Healthcare Biotechnology Frankfurt Exchange
0.0018 EUR
Close of Feb 24, 2024
905.39 1,322
Market cap
EUR 693K
P/E
-
P/B
4.33x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2023.

Is G09.F undervalued?

Graham number

The Graham number of Genomic Vision Société Anonyme cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Genomic Vision Société Anonyme fundamental analysis

No fundamental analysis for Genomic Vision Société Anonyme yet.

Genomic Vision Société Anonyme stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Genomic Vision Société Anonyme

Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company provides FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision S, an automated scanner that develops life science resear…

Full company profile